158 related articles for article (PubMed ID: 28392679)
1. Depressive symptoms and adherence to cardiometabolic therapies across phases of treatment among adults with diabetes: the Diabetes Study of Northern California (DISTANCE).
Bauer AM; Parker MM; Moffet HH; Schillinger D; Adler NE; Adams AS; Schmittdiel JA; Katon WJ; Karter AJ
Patient Prefer Adherence; 2017; 11():643-652. PubMed ID: 28392679
[TBL] [Abstract][Full Text] [Related]
2. Associations between antidepressant adherence and shared decision-making, patient-provider trust, and communication among adults with diabetes: diabetes study of Northern California (DISTANCE).
Bauer AM; Parker MM; Schillinger D; Katon W; Adler N; Adams AS; Moffet HH; Karter AJ
J Gen Intern Med; 2014 Aug; 29(8):1139-47. PubMed ID: 24706097
[TBL] [Abstract][Full Text] [Related]
3. Health literacy and antidepressant medication adherence among adults with diabetes: the diabetes study of Northern California (DISTANCE).
Bauer AM; Schillinger D; Parker MM; Katon W; Adler N; Adams AS; Moffet HH; Karter AJ
J Gen Intern Med; 2013 Sep; 28(9):1181-7. PubMed ID: 23512335
[TBL] [Abstract][Full Text] [Related]
4. Effect of Out-of-Pocket Cost on Medication Initiation, Adherence, and Persistence among Patients with Type 2 Diabetes: The Diabetes Study of Northern California (DISTANCE).
Karter AJ; Parker MM; Solomon MD; Lyles CR; Adams AS; Moffet HH; Reed ME
Health Serv Res; 2018 Apr; 53(2):1227-1247. PubMed ID: 28474736
[TBL] [Abstract][Full Text] [Related]
5. Communication and medication refill adherence: the Diabetes Study of Northern California.
Ratanawongsa N; Karter AJ; Parker MM; Lyles CR; Heisler M; Moffet HH; Adler N; Warton EM; Schillinger D
JAMA Intern Med; 2013 Feb; 173(3):210-8. PubMed ID: 23277199
[TBL] [Abstract][Full Text] [Related]
6. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions.
Karter AJ; Parker MM; Moffet HH; Ahmed AT; Schmittdiel JA; Selby JV
Health Serv Res; 2009 Oct; 44(5 Pt 1):1640-61. PubMed ID: 19500161
[TBL] [Abstract][Full Text] [Related]
7. Effects of gender and depression on oral medication adherence in persons with type 2 diabetes mellitus.
Nau DP; Aikens JE; Pacholski AM
Gend Med; 2007 Sep; 4(3):205-13. PubMed ID: 18022588
[TBL] [Abstract][Full Text] [Related]
8. Extent and reasons for nonadherence to antihypertensive, cholesterol, and diabetes medications: the association with depressive symptom burden in a sample of American veterans.
Weidenbacher HJ; Beadles CA; Maciejewski ML; Reeve BB; Voils CI
Patient Prefer Adherence; 2015; 9():327-36. PubMed ID: 25759567
[TBL] [Abstract][Full Text] [Related]
9. Importance of including early nonadherence in estimations of medication adherence.
Raebel MA; Carroll NM; Ellis JL; Schroeder EB; Bayliss EA
Ann Pharmacother; 2011 Sep; 45(9):1053-60. PubMed ID: 21852598
[TBL] [Abstract][Full Text] [Related]
10. Relationship of depression and diabetes self-care, medication adherence, and preventive care.
Lin EH; Katon W; Von Korff M; Rutter C; Simon GE; Oliver M; Ciechanowski P; Ludman EJ; Bush T; Young B
Diabetes Care; 2004 Sep; 27(9):2154-60. PubMed ID: 15333477
[TBL] [Abstract][Full Text] [Related]
11. An algorithm to identify medication nonpersistence using electronic pharmacy databases.
Parker MM; Moffet HH; Adams A; Karter AJ
J Am Med Inform Assoc; 2015 Sep; 22(5):957-61. PubMed ID: 26078413
[TBL] [Abstract][Full Text] [Related]
12. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.
Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
Clin Ther; 2009 Oct; 31(10):2178-88; discussion 2150-1. PubMed ID: 19922889
[TBL] [Abstract][Full Text] [Related]
13. Financial Strain and Medication Adherence among Diabetes Patients in an Integrated Health Care Delivery System: The Diabetes Study of Northern California (DISTANCE).
Lyles CR; Seligman HK; Parker MM; Moffet HH; Adler N; Schillinger D; Piette JD; Karter AJ
Health Serv Res; 2016 Apr; 51(2):610-24. PubMed ID: 26256117
[TBL] [Abstract][Full Text] [Related]
14. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs.
Ciechanowski PS; Katon WJ; Russo JE
Arch Intern Med; 2000 Nov; 160(21):3278-85. PubMed ID: 11088090
[TBL] [Abstract][Full Text] [Related]
15. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
16. Tangled Up in Blue: Unraveling the Links Between Emotional Distress and Treatment Adherence in Type 2 Diabetes.
Gonzalez JS; Kane NS; Binko DH; Shapira A; Hoogendoorn CJ
Diabetes Care; 2016 Dec; 39(12):2182-2189. PubMed ID: 27797932
[TBL] [Abstract][Full Text] [Related]
17. Alcohol screening scores and medication nonadherence.
Bryson CL; Au DH; Sun H; Williams EC; Kivlahan DR; Bradley KA
Ann Intern Med; 2008 Dec; 149(11):795-804. PubMed ID: 19047026
[TBL] [Abstract][Full Text] [Related]
18. Association of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease.
Dempe C; Jünger J; Hoppe S; Katzenberger ML; Möltner A; Ladwig KH; Herzog W; Schultz JH
J Psychosom Res; 2013 Feb; 74(2):122-7. PubMed ID: 23332526
[TBL] [Abstract][Full Text] [Related]
19. Prescriber continuity and medication adherence for complex patients.
Hansen RA; Voils CI; Farley JF; Powers BJ; Sanders LL; Sleath B; Maciejewski ML
Ann Pharmacother; 2015 Mar; 49(3):293-302. PubMed ID: 25549627
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
